XBiotech Inc.

Develops therapeutic antibodies from natural human immunity for inflammatory diseases and oncology.

XBIT | US

Overview

Corporate Details

ISIN(s):: CA98400H1029
LEI:
Country:: United States of America
Address:: 5217 WINNEBAGO LANE, 78744 AUSTIN
Website:: https://www.xbiotech.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

XBiotech Inc. is a fully integrated, clinical-stage biosciences company specializing in the discovery, development, and commercialization of therapeutic antibodies. The company's core innovation is its proprietary True Human™ platform, which develops monoclonal antibodies derived directly from the natural immunity of human donors. This approach aims to create therapies that are potentially safer and more effective than engineered antibodies. XBiotech's pipeline targets a range of unmet medical needs, with a focus on diseases involving inflammation. Key therapeutic areas include oncology, neurology, rheumatology, and anti-infectives. The company maintains control over the entire process, from antibody discovery and clinical research to its in-house manufacturing capabilities.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all XBiotech Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for XBiotech Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for XBiotech Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
biote Corp. Trains practitioners in hormone optimization using bioidentical pellets and nutraceuticals.	United States of America	BTMD
Biotest AG Develops plasma protein products & biotherapeutics for immunology, haematology & intensive care.	Germany	BIO3
Biotika A.S. Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.	Slovakia	BSL
Bioton S.A. Develops and manufactures recombinant human insulin for global diabetes care solutions.	Poland	BIO
BIOVENTIX PLC Develops high-affinity sheep monoclonal antibodies for global clinical diagnostic immunoassays.	United Kingdom	BVXP
Bioversys N Develops novel therapeutics to combat antimicrobial resistance in life-threatening infections.	Switzerland	BIOV
Biovica International B Develops blood tests to monitor the efficacy of solid tumor cancer therapies.	Sweden	BIOVIC
BIOVIE INC. Develops drug therapies for Alzheimer's, Parkinson's, and advanced liver diseases by targeting inflammation.	United States of America	BIVI
BioXcel Therapeutics, Inc. AI-driven biopharma developing treatments for neuroscience and immuno-oncology.	United States of America	BTAI
Black Diamond Therapeutics, Inc. Develops precision oncology drugs targeting mutation families in lung and brain cancers.	United States of America	BDTX